SecBot SecBot

BAK

BRASKEM SA
NYSE· Industrial Organic Chemicals· CIK 0001071438 Biotech & Drug Discovery
$1.10 −0.60 (−35.29%)
Oct 26 4:00 PM ET · prev $1.70
Market cap
$637.8M
Small cap
Consensus
Sell
0% Buy or better · 15 analysts
Median target
$1.50
+36% · range $1.50–2.00
1 year
−59.6%
from $2.72 · Oct 27
30 days
−26.2%
from $1.49
52-week range
$1.10–5.02
at the low
Avg volume 20D
2.65M
Oct 26 spike 16.42M
Short interest
5.65M
≈1.4% of shares · +24.6%
Days to cover
3.6
at average volume
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
53
analyzed by SecBot
SecBot read BEARISH 21 reports · 90 days
Balance 15 bearish · 0 bullish · 2 mixed · 4 neutral oldest → newest, height = score
Avg score ·High conf. 17/21

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q2 2026: 7 added (0 new), 5 trimmed or exited.

  • AnalystsBEARISH

    0 of 15 rate it Buy or better. Every target is above the price.

  • Short sellersBUILDING

    Short interest +24.6% to 5.65M shares. 3.6 days to cover, ≈1.4% of shares.

  • TrendDOWNTREND

    37% below its 50-day average. New closing low $1.10 on Oct 26.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
MARSHALL WACE, LLPDOUBLED2,019,382$4.9M
Point72 Asset Management, L.P.DOUBLED1,233,885$3.0M
JANE STREET GROUP, LLCADD820,304$2.0M
UBS Group AGADD760,743$1.9M
MILLENNIUM MANAGEMENT LLCDOUBLED163,695$399.4K
GOLDMAN SACHS GROUP INCADD50,889$124.2K
MORGAN STANLEYNEAR_EXIT38,057$92.9K
Centiva Capital, LPADD28,690$70.0K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

15 analysts
Sell 0% rate it Buy or better
Strong Buy0Buy0Hold8Sell3Strong Sell4
12-month targets · 5 analysts

Price is below the lowest target. Median implies +36%.Targets as of Oct 26, 2026.

Recent actions
DateFirmActionRating
Sep 28, 2026HSBC
DOWNGRADE
DOWNGRADEHold
Sep 16, 2026UBS
DOWNGRADE
DOWNGRADESell
Jun 30, 2026JP Morgan
DOWNGRADE
DOWNGRADENeutral
Jun 26, 2026Citigroup
DOWNGRADE
DOWNGRADESell

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

Short side

FINRA· Sep 30, 2026
5,654,923
shares short
+24.6%
vs prior settlement
3.6
days to cover
≈1.4%
of shares outstanding
Trading halts
Aug 28, 2026Resumption ScheduledResumed
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 26, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Oct 21, 2026 SEC
Braskem filed a Code of Conduct update (routine governance document) and disclosed that NSP Investimentos S.A. – em…
6-K — Impact 3/10
Oct 21, 2026 SEC
Creditors holding ~47% ($272M) of Braskem America Finance's $589M in 7.125% Notes due 2041 filed an involuntary…
6-K — Impact 7/10
Aug 28, 2026 Trading halt
Halt Resumed: BAK — trading resumed after T3 (News and Resumption Times)
Halted 2026-08-28T13:03:04.000Z | Resumed 2026-08-28T13:46:10.000Z
Jun 30, 2026 Inst.
MARSHALL WACE, LLP — DOUBLED
2,019,382 shares ($4.9M)
Jun 30, 2026 Inst.
Point72 Asset Management, L.P. — DOUBLED
1,233,885 shares ($3.0M)

SecBot reports

53 filings · 1 bullish · 20 bearish · 6 mixed · 26 neutral
All BAK filing & press-release reports (53)